You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Safety of artemether-lumefantrine exposure in first trimester of pregnancy: an observational cohort
|
---|---|
Published in |
Malaria Journal, May 2014
|
DOI | 10.1186/1475-2875-13-197 |
Pubmed ID | |
Authors |
Dominic Mosha, Festo Mazuguni, Sigilbert Mrema, Esperanca Sevene, Salim Abdulla, Blaise Genton |
Abstract |
There is limited data available regarding safety profile of artemisinins in early pregnancy. They are, therefore, not recommended by WHO as a first-line treatment for malaria in first trimester due to associated embryo-foetal toxicity in animal studies. The study assessed birth outcome among pregnant women inadvertently exposed to artemether-lumefantrine (AL) during first trimester in comparison to those of women exposed to other anti-malarial drugs or no drug at all during the same period of pregnancy. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 2 | 67% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 125 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Tanzania, United Republic of | 2 | 2% |
Switzerland | 1 | <1% |
Ethiopia | 1 | <1% |
Botswana | 1 | <1% |
Kenya | 1 | <1% |
United Kingdom | 1 | <1% |
Unknown | 118 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 25 | 20% |
Researcher | 14 | 11% |
Student > Ph. D. Student | 13 | 10% |
Student > Bachelor | 12 | 10% |
Student > Postgraduate | 8 | 6% |
Other | 28 | 22% |
Unknown | 25 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 45 | 36% |
Nursing and Health Professions | 11 | 9% |
Agricultural and Biological Sciences | 10 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 8 | 6% |
Social Sciences | 6 | 5% |
Other | 18 | 14% |
Unknown | 27 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 January 2024.
All research outputs
#6,282,360
of 23,577,654 outputs
Outputs from Malaria Journal
#1,648
of 5,653 outputs
Outputs of similar age
#57,977
of 228,152 outputs
Outputs of similar age from Malaria Journal
#25
of 102 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 5,653 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 228,152 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 102 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.